Top Industry Leaders in the Immunoassay Market
Latest Immunoassay Companies Update
Roche (Switzerland) acquires LumiraDx Point-of-Care Testing technology for up to USD 350 million, aiming to expand its offerings in rapid diagnostic testing for infectious diseases.DiaSorin (Italy) announces plans to launch several new instruments and updated assays in 2024 and 2025, strengthening its position in the autoimmune and infectious disease diagnostics market.QuidelOrtho (US) receives Health Canada approval for its Quidel TriageTrue High-Sensitivity Troponin I (hsTnl) Test, offering a new tool for early detection of heart attacks.Abcam (UK) partners with Fujirebio Diagnostics (Japan) to develop and manufacture immunoassays for autoimmune and infectious diseases, combining their expertise for innovative diagnostic solutions.Hangzhou Clongene Biotech (China) secures a distribution deal with Gold Colloid Sign (US) for its rapid tests, expanding its reach in the North American market.List of Immunoassay Key companies in the market
-
Siemens Healthineers,
-
Abbott Laboratories,
-
Becton Merck KGaA,
-
Sysmex Corporation,
-
Ortho-Clinical Diagnostics/Carlyle Group,
-
Dickinson and Company,
-
Danaher Corporation,
-
Thermo Fisher Scientific Inc.,
-
Hoffmann-La Roche Ltd,
-
bioMérieux SA,Quidel Corporation,
-
DiaSorin S.p. A.